Bronchial Asthma
Conditions
Interventions
research group: natural moxibustion acupoint application
Sponsors
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1 Patients who are diagnosed as chronic duration and clinical remission of bronchial asthma in Western medicine; 2 Patients who are diagnosed with Chinese medicine asthma lung and kidney qi deficiency syndrome; 3 The severity of the disease is classified as mildly persistent or moderately persistent; 4 Aged 18 to 75 years, both men and women; 5 Those who voluntarily receive the drug and sign the informed consent form (the informed consent process complies with the GCP requirements).
Exclusion criteria
Exclusion criteria: 1 other diseases with airflow obstruction, such as chronic obstructive pulmonary disease, bronchiectasis, pulmonary tuberculosis, diffuse panbronchiolitis and other patients; 2 patients with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, upper extremity ankle amputation and hematopoietic dysfunction; 3 mental patients and those who cannot be treated for other reasons; 4 pregnant or lactating women; 5 It is known that those who are allergic to the test ingredients and the skin of the treatment site have blistering, sputum, damage and fever.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1; | — |
Secondary
| Measure | Time frame |
|---|---|
| IL-5, IL-13, IL-23, IL-25, TSLP;The Asthma Quality of Life;Metallothionein-2, Transgelin-2;Asthma control test; | — |
Countries
China
Contacts
Public ContactJun He
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Outcome results
None listed